Shaaltiel Yoseph

CIK 00013851181 companyCARMIEL, L3

SEC Profile

Transactions

Companies

Filings

CIK

0001385118

Recent Transactions

27 trades

Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2018-09-13+700,000→ 700,000 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2016-09-15$0.00/sh+122,162→ 585,916 total
Exercise/Conversion
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2016-09-15−122,162→ 0 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2015-03-23+275,000→ 275,000 total
Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-07-16+210,000→ 210,000 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2012-05-02$7.13/sh−300,000→ 463,754 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-08-06$7.00/sh−4,619→ 763,754 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-08-05$7.00/sh−48,408→ 768,373 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-06-21$7.00/sh−52,973→ 816,781 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-04-29$7.00/sh−12,691→ 869,754 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-04-14$7.00/sh−1,309→ 882,445 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-03-25$7.00/sh−50,000→ 883,754 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-03-24$7.08/sh−202,700→ 933,754 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2010-03-23$7.02/sh−127,300→ 1,136,454 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2010-02-25+145,000→ 145,000 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-19$9.43/sh−43,120→ 1,263,754 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-16$9.39/sh−25,680→ 1,306,874 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-10-15$9.39/sh−31,200→ 1,332,554 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-07-06$4.95/sh−20,000→ 1,363,754 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-07-06$5.13/sh−80,000→ 1,383,754 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-14$3.85/sh−10,000→ 1,463,754 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-05-13$3.51/sh−20,000→ 1,473,754 total
Sale
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2009-03-13$2.18/sh−8,300→ 1,493,754 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2009-02-25+50,000→ 50,000 total
Purchase
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2007-12-05$3.16/sh+3,300→ 2,959,207 total
Purchase
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2007-12-05$3.15/sh+9,700→ 2,955,907 total
Purchase
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2007-12-05$3.05/sh+2,100→ 2,946,207 total

Companies

Protalix BioTherapeutics, Inc.
Director, Executive VP, R&D
$PLX

Recent Filings

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, POB 455

CARMIEL, L3, 20100

View on SEC.gov